Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3Thoracic 2Gynecologic 2Genitourinary 2Other solid neoplasm 1Head & Neck 1Endocrine 1Breast 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 2Stomach Neoplasms 1Rectal Neoplasms 1Pancreatic Neoplasms 1Mesothelioma, Malignant 1Gallbladder Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Bile Duct Neoplasms 1Appendiceal Neoplasms 1Anus Neoplasms 1

Interventions

pembrolizumab 1entinostat 1Quality of Life 1Patient Reported Outcome Measures 1Molecular Diagnostic Techniques 1Interleukin-12 Subunit p35 1Immunotherapy 1Fentanyl 1Drug Therapy 1Biological Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Bile Duct Neoplasms × Interleukin-12 Subunit p35 × Other solid neoplasm × Clear all
NCT00003046 2012-07-30

Interleukin-12 in Treating Patients With Cancer in the Abdomen

M.D. Anderson Cancer Center

Phase 1 Completed
29 enrolled
GastrointestinalOther solid neoplasmThoracic

Mesothelioma, Malignant, Anus Neoplasms, Appendiceal Neoplasms, Bile Duct Neoplasms, Colonic Neoplasms, Gallbladder Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡